Report: Bayer Delayed Warning on Cholesterol Drug
10668
Bayer AG may have known its withdrawn cholesterol-lowering drug Baycol caused a high rate of a serious muscle condition more than a year before it added a warning to its label, according to a prominent medical journal.
102166
U.S. regulators on Friday delayed a  decision on whether to approve over-the-counter sales of a Barr  Pharmaceuticals "morning-after pill" to prevent pregnancy,  prompting a lawsuit from a women's rights group.
452664
German drug maker Bayer AG "mistakenly" failed to inform U.S. regulators about a study on the risks of heart-surgery drug Trasylol before an advisory panel met and ruled the side effects were acceptable, the company said on Friday.
524084
The warning that Eli Lilly &amp; Co. issued last week about its attention-deficit disorder drug Strattera is much narrower than was reported in Saturday&#39;s editions of The Times-Dispatch.
505877
Bayer HealthCare stopped a late-stage trial of Nexavar in patients with non-small cell lung cancer after a monitoring committee concluded the study would not improve overall survival.
419188
German drug maker Altana said that it had postponed its application for approval of its new asthma treatment Roflumilast in the United States because additional clinical trials on the drug were taking longer than expected.
326529
A new study indicates that a Bayer statin drug called âBaycol&#39; should have been taken off the market earlier. Statins are drugs that lower your cholesterol level.
692172
German drug group Bayer said Monday that it had halted trials of its leading cancer treatment Nexavar for one of the main forms of lung cancer.
171919
U.S. regulators said on Friday they  would review whether to take action over Merck & Co Inc's   and Schering-Plough Corp's  popular cholesterol  medicine Vytorin after a study showed it was no better than a  generic drug in preventing the build-up of fatty plaque.
237444
The Food and Drug Administration will consider whether one of the oldest of the cholesterol-lowering drugs, Mevacor, can be sold without a prescription.
385311
Shares of Onyx Pharmaceuticals Inc. plunged after it and partner Bayer Pharmaceuticals Corp. said Monday they will use ongoing late-stage clinical trial data to seek marketing approval of their kidney cancer
611882
WASHINGTON Dec 22, 2004 - The Food and Drug Administration is seeking to block an ad touting the safety of the cholesterol drug Crestor, calling the claims misleading.
171695
What you hear before taking prescription drugs versus what you learn afterward may make you feel like a lab rat. Before: Bayer&#39;s Baycol lowers cholesterol.
472584
NEW YORK - In a capstone to the withdrawal of Vioxx, the US Food and Drug Administration has decided to delay the approval of successor drug Arcoxia until more safety data are available.
13024
U.S. regulators have asked for more data on Novartis AG's  diabetes drug Galvus, possibly delaying approval of the potential blockbuster by a year, which dented its shares while boosting its main rival's.
687262
A U.S. advisory panel on Friday urged regulators to reject over-the-counter sales of Merck & Co. Inc.'s  cholesterol-lowering drug Mevacor.
388679
A long, suspicious delay in the study of Merck and Schering's $5 billion drug was reported by Forbes in November.